Mae'r dogfennau caffael ar gael ar gyfer mynediad uniongyrchol anghyfyngedig a llawn, yn rhad ac am ddim ar:
II.1.1) Teitl
NHS England South East - Diabetic Eye Screening Programmes (DESP)
Cyfeirnod: C253273
II.1.2) Prif god CPV
85100000
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
NHS England South East (NHSE) is seeking to commission a Provider(s) who have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements.
The procurement is divided into 5 lots within the South East as follows:
Lot 1: Kent and Medway (ICB Footprint)
Lot 2: Surrey Heartlands (ICB Footprint)
Lot 3: Hampshire and IOW (ICB Footprint)
Lot 4: Berkshire (Local Authority) and Frimley (ICB Footprint)
Lot 5: Oxfordshire and Buckinghamshire (Local Authority Footprint)
Providers may bid for one or all Lots. The Contracts will be for a term of 5 years, with the option to extend by 3 years, and services are planned to commence from 1st April 2025.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
• focus on improving uptake, reducing inequalities and improving outcomes
• is accessible across all service elements
• Is engaged, engaging and integrated, working effectively with service users and stakeholders to ensure seamless and high quality care
• safe, effective, high quality, wiht robust processes along the pathway
•
• embeds a culture of quality, improvement and learning
• is well-led, managed and staffed
There are three key elements of service delivery, namely:
• routine digital screening - from 2025 and 2026 all eligible patients should be managed on 12 or 24 month intervals .
• Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
Further information on the Diabetic Eye Screening Programme is available at;
https://www.gov.uk/topic/population-screening-programmes/diabetic-eye
The projected total contract values are as follows:
Lot 1: Kent and Medway - £17,755,303
Lot 2: Surrey Heartlands - £8,084,825
Lot 3: Hampshire and IOW - £16,695,800
Lot 4: Berkshire and Frimley - £11,311,121
Lot 5: Oxfordshire and Buckinghamshire - £9,927,015
TUPE is likely to apply to this procurement.
This exercise is being managed by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioner(s).
Interested providers will be able to view the opportunity and access the tender documentation via the 'Live Opportunities' list on the e-procurement system, Atamis, available on the following link: https://health-family.force.com/s/Welcome
II.1.5) Cyfanswm gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 63 774 064.00 GBP
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Ydy
Gellir cyflwyno tendrau ar gyfer pob lot
Rhif y Lot 1
II.2.1) Teitl
Kent and Medway
II.2.2) Cod(au) CPV ychwanegol
85100000
II.2.3) Man cyflawni
Cod NUTS:
UKJ4
II.2.4) Disgrifiad o’r caffaeliad
NHS England South East (NHSE) is seeking to commission a Provider(s) who have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements.
Providers may bid for one or all Lots. The Contracts will be for a term of 5 years, with the option to extend by 3 years, and services are planned to commence from 1st April 2025.
The procurement is divided into 5 lots. Lot 1 covers Kent and Medway and has an eligible population of around 124,000 people. Please refer to the lot data sheet included within the tender documents for more information.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
• Identifies the eligible population and ensures effective delivery with maximum coverage
• Is safe, effective, high quality, externally and independently monitored, and quality assured
• Leads to earlier detection, appropriate referral, effective treatment and improved outcomes
• Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous professional development (CPD) and quality assurance (QA) schemes
• Has audit embedded in the service
• Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.
There are three key elements of service delivery, namely:
• Routine digital screening - from 2025 and 2026 all eligible patients should be managed on 12 or 24 month intervals for routine diabetic eye screening.
• Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.6) Gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 17 755 303.00 GBP
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Hyd mewn misoedd: 96
Gall y contract hwn gael ei adnewyddu: Na
II.2.9) Gwybodaeth am y cyfyngiadau ar nifer yr ymgeiswyr a gaiff eu gwahodd
II.2.10) Gwybodaeth am amrywiadau
Derbynnir amrywiadau:
Na
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Rhif y Lot 2
II.2.1) Teitl
Surrey Heartlands
II.2.2) Cod(au) CPV ychwanegol
85100000
II.2.3) Man cyflawni
Cod NUTS:
UKJ2
II.2.4) Disgrifiad o’r caffaeliad
NHS England South East (NHSE) is seeking to commission a Provider(s) who have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements., in line with the specified requirements.
The procurement is divided into 5 lots. Lot 2 covers Surrey Heartlands and has an eligible population of around 56,000 people. Please refer to the lot data sheet included within the tender documents for more information.
Providers may bid for one or all Lots. The Contracts will be for a term of 5 years, with the option to extend by 3 years, and services are planned to commence from 1st April 2025.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
• Identifies the eligible population and ensures effective delivery with maximum coverage
• Is safe, effective, high quality, externally and independently monitored, and quality assured
• Leads to earlier detection, appropriate referral, effective treatment and improved outcomes
• Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous professional development (CPD) and quality assurance (QA) schemes
• Has audit embedded in the service
• Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.
There are three key elements of service delivery, namely:
• Routine digital screening - from 2025 and 2026 all eligible patients should be managed on 12 or 24 month intervals for routine diabetic eye screening.
• Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.6) Gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 8 084 825.00 GBP
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Hyd mewn misoedd: 96
Gall y contract hwn gael ei adnewyddu: Na
II.2.9) Gwybodaeth am y cyfyngiadau ar nifer yr ymgeiswyr a gaiff eu gwahodd
II.2.10) Gwybodaeth am amrywiadau
Derbynnir amrywiadau:
Na
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Rhif y Lot 3
II.2.1) Teitl
Hampshire and Isle of Wight
II.2.2) Cod(au) CPV ychwanegol
85100000
II.2.3) Man cyflawni
Cod NUTS:
UKJ3
II.2.4) Disgrifiad o’r caffaeliad
NHS England South East (NHSE) is seeking to commission a Provider(s) who have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements., in line with the specified requirements.
The procurement is divided into 5 lots. Lot 3 covers the Hampshire and Isle of Wight ICB area and has an eligible population of around 117,000 people Please refer to the lot data sheet included within the tender documents for more information.
Providers may bid for one or all Lots. The Contracts will be for a term of 5 years, with the option to extend by 3 years, and services are planned to commence from 1st April 2025.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
• Identifies the eligible population and ensures effective delivery with maximum coverage
• Is safe, effective, high quality, externally and independently monitored, and quality assured
• Leads to earlier detection, appropriate referral, effective treatment and improved outcomes
• Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous professional development (CPD) and quality assurance (QA) schemes
• Has audit embedded in the service
• Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.
There are three key elements of service delivery, namely:
• Routine digital screening - from 2025 and 2026 all eligible patients should be managed on 12 or 24 month intervals for routine diabetic eye screening.
• Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.6) Gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 16 695 800.00 GBP
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Hyd mewn misoedd: 96
Gall y contract hwn gael ei adnewyddu: Na
II.2.9) Gwybodaeth am y cyfyngiadau ar nifer yr ymgeiswyr a gaiff eu gwahodd
II.2.10) Gwybodaeth am amrywiadau
Derbynnir amrywiadau:
Na
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Rhif y Lot 4
II.2.1) Teitl
Berkshire & Frimley
II.2.2) Cod(au) CPV ychwanegol
85100000
II.2.3) Man cyflawni
Cod NUTS:
UKJ
II.2.4) Disgrifiad o’r caffaeliad
NHS England South East (NHSE) is seeking to commission a Provider(s) who have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements., in line with the specified requirements.
The procurement is divided into 5 lots. Lot 4 covers all of Berkshire and thethe Frimley ICB area and has an eligible population of around 79,000. Please refer to the lot data sheet included within the tender documents for more information.
Providers may bid for one or all Lots. The Contracts will be for a term of 5 years, with the option to extend by 3 years, and services are planned to commence from 1st April 2025.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
• Identifies the eligible population and ensures effective delivery with maximum coverage
• Is safe, effective, high quality, externally and independently monitored, and quality assured
• Leads to earlier detection, appropriate referral, effective treatment and improved outcomes
• Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous professional development (CPD) and quality assurance (QA) schemes
• Has audit embedded in the service
• Works effectively with other stakeholders to ensure the care pathway is smooth and efficient.
There are three key elements of service delivery, namely:
• Routine digital screening - from 2025 and 2026 all eligible patients should be managed on 12 or 24 month intervals for routine diabetic eye screening.
• Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.6) Gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 11 311 121.00 GBP
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Hyd mewn misoedd: 96
Gall y contract hwn gael ei adnewyddu: Na
II.2.9) Gwybodaeth am y cyfyngiadau ar nifer yr ymgeiswyr a gaiff eu gwahodd
II.2.10) Gwybodaeth am amrywiadau
Derbynnir amrywiadau:
Na
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Rhif y Lot 5
II.2.1) Teitl
Oxfordshire and Buckinghamshire
II.2.2) Cod(au) CPV ychwanegol
85100000
II.2.3) Man cyflawni
Cod NUTS:
UKJ1
II.2.4) Disgrifiad o’r caffaeliad
NHS England South East (NHSE) is seeking to commission a Provider(s) who have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements., in line with the specified requirements.
The procurement is divided into 5 lots. Lot 5 covers the whole of Buckinghamshire and Oxfordshire and has an eligible population of around 69,000 people. Please refer to the lot data sheet included within the tender documents for more information.
Providers may bid for one or all Lots. The Contracts will be for a term of 5 years, with the option to extend by 3 years, and services are planned to commence from 1st April 2025.
The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units and the armed forces.
The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy.
This will be achieved by delivering an evidence-based service that:
• ##########
There are three key elements of service delivery, namely:
• Routine digital screening - from 2025 and 2026 all eligible patients should be managed on 12 or 24 month intervals for routine diabetic eye screening.
• Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required.
• Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts).
Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance.
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.6) Gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 9 927 015.00 GBP
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Hyd mewn misoedd: 96
Gall y contract hwn gael ei adnewyddu: Na
II.2.9) Gwybodaeth am y cyfyngiadau ar nifer yr ymgeiswyr a gaiff eu gwahodd
II.2.10) Gwybodaeth am amrywiadau
Derbynnir amrywiadau:
Na
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Interested providers will be able to view this opportunity via the live opportunities list on the 'Health Family' e-procurement system, Atamis. Click on 'View our Live Opportunities' from the home page, available on the following link: https://health-family.force.com/s/Welcome.
Once you have found the opportunity (via the search function, using the title or reference number), to gain full access to the bid documentation (including questionnaires), you will need to click on 'Register interest' - this will take you to the log-in page.
If you are not already registered on the system, you will need to do so before gaining full access to the documentation and be able to submit a bid.
This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.